PWP
GILD icon

Parkwoods Wealth Partners’s Gilead Sciences GILD Stock Holding History

Parkwoods Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Buy
+1,935
New +$255K 0.04% 150

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Parkwoods Wealth Partners's GILD Position: Q2 2026 in Review

Parkwoods Wealth Partners opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,935 shares worth $244K. The stake represents 0.04% of the portfolio and ranks #150 among its holdings.

2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Parkwoods Wealth Partners held 1,935 shares of Gilead Sciences worth $244K as of Q2 2026.
  • Gilead Sciences was a new Parkwoods Wealth Partners position in Q2 2026.
  • Gilead Sciences made up 0.04% of Parkwoods Wealth Partners's portfolio in Q2 2026, its #150 holding.
  • 2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Parkwoods Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.